SCHEMBL30020102

SCHEMBL30020102

COc1cc(N2CCN(C)CC2)c(F)cc1[N+](=O)[O-]

nearest known ligand 0.69

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MAPT P10636 12/20 0.69
ALDH1A1 P00352 7/20 0.69
SMN1; SMN2 Q16637 2/20 0.69
CYP1A2 P05177 2/20 0.69
CYP2C9 P11712 2/20 0.69
CYP2C19 P33261 2/20 0.69
CYP2D6 P10635 1/20 0.69
LMNA P02545 4/20 0.67
SIRT6 Q8N6T7 1/20 0.61
GAA P10253 2/20 0.58
NPSR1 Q6W5P4 1/20 0.57
PKM P14618 1/20 0.51
MAPK1 P28482 2/20 0.50
GPR174 Q9BXC1 1/20 0.49
WDR5 P61964 1/20 0.48
MEN1 O00255 1/20 0.48
KMT2A Q03164 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12312120 0.89 SIRT6 (0.64) MAPTALDH1A1SMN1; SMN2CYP1A2CYP2C9
SCHEMBL17410984 0.89 MAPT (0.55) MAPTALDH1A1SMN1; SMN2CYP1A2CYP2C9
SCHEMBL517969 0.88 MAPT (0.55) MAPTALDH1A1SMN1; SMN2CYP1A2CYP2C9
SCHEMBL30636459 0.88 MAPT (0.55) MAPTALDH1A1SMN1; SMN2CYP1A2CYP2C9
SCHEMBL22028444 0.86 SIRT6 (0.61) MAPTALDH1A1SMN1; SMN2CYP1A2CYP2C9
SCHEMBL16513593 0.85 MAPT (0.76) MAPTALDH1A1SMN1; SMN2CYP1A2CYP2C9
SCHEMBL29847854 0.85 MAPT (0.76) MAPTALDH1A1SMN1; SMN2CYP1A2CYP2C9
SCHEMBL31342113 0.85 MAPT (0.58) MAPTALDH1A1SMN1; SMN2CYP1A2CYP2C9
SCHEMBL2206124 0.85 MAPT (0.51) MAPTALDH1A1SMN1; SMN2CYP1A2CYP2C9
SCHEMBL27057394 0.85 MAPT (0.64) MAPTALDH1A1SMN1; SMN2CYP1A2CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116981664-A Thienyl and cycloalkyl aminopyrimidine compounds as inhibitors of NUAK kinase, compositions and uses thereof 安大略省癌症研究所(OICR) 2023-10-31 CN disclosed
WO-2022226290-A1 2-PHENYLAMINO PYRROLOPYRIMIDINES AS ACK1 INHIBITORS H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC. (US) 2022-10-27 WO disclosed